You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Novel Trial Refutes All Expectations

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Impact Factor: 1.7 / 5-Year Impact Factor: 1.7

Journal Homepage Submission guidelines

Restricted access

Research article

First published online April, 2004

Novel Trial Refutes All Expectations

Volume 137, Issue 3

https://doi.org/10.1177/171516350413700304

Abstract

Get full access to this article

View all access options for this article.

References

1.

Cannon

CP

Braunwald

E

McCabe

CH

Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. NEJM 2004;350.

2.

Nissen

SE

Tuzcu

M

Schoenhagen

P

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071–80.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

New Generic Pricing Rules Come to Newfoundland and Labrador and New Brunswick

Retricted access

Pharmacological evaluation of methanolic leaf extract of Swietenia mahagoni on acrylamide-induced neuropathic pain in rats

Retricted access

University of Waterloo Celebrates Innovation and Entrepreneurship

Retricted access

Monoclonal Antibody That Recognizes a Domain on Heterogeneous Nuclear Ribonucleoprotein K and PTB-Associated Splicing Factor